MAZE
Maze Therapeutics Inc.

70
Mkt Cap
$1.98B
Volume
273,986.00
52W High
$43.29
52W Low
$6.71
PE Ratio
-17.66
MAZE Fundamentals
Price
$39.81
Prev Close
$41.11
Open
$41.30
50D MA
$37.88
Beta
1.06
Avg. Volume
467,919.27
EPS (Annual)
$0.0778
P/B
5.04
Rev/Employee
$1.34M
Loading...
Loading...
News
all
press releases
Maze Therapeutics (NASDAQ:MAZE) CMO Sells 25,156 Shares
Maze Therapeutics, Inc. (NASDAQ:MAZE - Get Free Report) CMO Harold Bernstein sold 25,156 shares of the business's stock in a transaction dated Wednesday, January 7th. The stock was sold at an average...
MarketBeat·6d ago
News Placeholder
More News
News Placeholder
Maze Therapeutics (NASDAQ:MAZE) CMO Harold Bernstein Sells 4,432 Shares
Maze Therapeutics, Inc. (NASDAQ:MAZE - Get Free Report) CMO Harold Bernstein sold 4,432 shares of the stock in a transaction dated Friday, January 2nd. The stock was sold at an average price of...
MarketBeat·9d ago
News Placeholder
Insider Selling: Maze Therapeutics (NASDAQ:MAZE) CMO Sells 412 Shares of Stock
Maze Therapeutics, Inc. (NASDAQ:MAZE - Get Free Report) CMO Harold Bernstein sold 412 shares of the company's stock in a transaction on Monday, January 5th. The stock was sold at an average price of...
MarketBeat·9d ago
News Placeholder
Harold Bernstein Sells 4,432 Shares of Maze Therapeutics (NASDAQ:MAZE) Stock
Maze Therapeutics, Inc. (NASDAQ:MAZE - Get Free Report) CMO Harold Bernstein sold 4,432 shares of the business's stock in a transaction on Friday, January 2nd. The stock was sold at an average price...
MarketBeat·9d ago
News Placeholder
Maze Therapeutics (NASDAQ:MAZE) SVP Amy Bachrodt Sells 5,000 Shares
Maze Therapeutics, Inc. (NASDAQ:MAZE - Get Free Report) SVP Amy Bachrodt sold 5,000 shares of Maze Therapeutics stock in a transaction dated Friday, January 2nd. The stock was sold at an average...
MarketBeat·9d ago
News Placeholder
Maze Therapeutics (NASDAQ:MAZE) Trading Down 4.9% - Here's Why
Maze Therapeutics (NASDAQ:MAZE) Trading Down 4.9% - Time to Sell...
MarketBeat·14d ago
News Placeholder
Insider Selling: Maze Therapeutics (NASDAQ:MAZE) CMO Sells 45,000 Shares of Stock
Maze Therapeutics, Inc. (NASDAQ:MAZE - Get Free Report) CMO Harold Bernstein sold 45,000 shares of the company's stock in a transaction that occurred on Monday, December 29th. The shares were sold at...
MarketBeat·15d ago
News Placeholder
Insider Selling: Maze Therapeutics (NASDAQ:MAZE) SVP Sells 5,000 Shares of Stock
Maze Therapeutics, Inc. (NASDAQ:MAZE - Get Free Report) SVP Amy Bachrodt sold 5,000 shares of the firm's stock in a transaction that occurred on Tuesday, December 30th. The stock was sold at an...
MarketBeat·15d ago
News Placeholder
Amy Bachrodt Sells 10,000 Shares of Maze Therapeutics (NASDAQ:MAZE) Stock
Maze Therapeutics, Inc. (NASDAQ:MAZE - Get Free Report) SVP Amy Bachrodt sold 10,000 shares of the stock in a transaction dated Monday, December 29th. The stock was sold at an average price of...
MarketBeat·15d ago
News Placeholder
Maze Therapeutics (NASDAQ:MAZE) Insider Sells $2,936,544.00 in Stock
Maze Therapeutics, Inc. (NASDAQ:MAZE - Get Free Report) insider Atul Dandekar sold 72,400 shares of Maze Therapeutics stock in a transaction that occurred on Monday, December 29th. The stock was sold...
MarketBeat·15d ago
<
1
2
...
>

Latest MAZE News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.